Professional Publications

Vymazal, O.; Bendíčková, K.; De Zuani, M.; Vlková, M.; Hortová-Kohoutková, M.; Frič, J.

Immunosuppression affects neutrophil functions: does calcineurin-NFAT signaling matter?

[year of publication 2021, impact factor 7.561 ]

Vaisocherová, H.; Šípová, H.; Víšová, I.; Bocková, M.; Špringer, T.; Laura Ermini, M.; Song, X.; Krejčík, Z.; Chrastinová, L.; Pastva, O.; Pimková, K.; Dostálová Merkerová, M.; Dyr, J.E.; Homola, J.

Rapid and sensitive detection of multiple microRNAs in cell lysate by low-fouling surface plasmon resonance biosensor

[year of publication 2015, impact factor 7.476 ]

Ranganathan, V.; Heine, W.F.; Ciccone, D.N.; Rudolph, K.L.; Wu, X.; Chang, S.; Hai, H.; Ahearn, I.M.; Livingston, D.M.; Resnick, I.; Rosen, F.; Seemanova, E.; Jarolim, P.; DePinho, R.A.; Weaver, D.T.

Rescue of a telomere length defect of Nijmegen Breakage Syndrome cells requires NBS and telomerase catalytic subunit

[year of publication 2006, impact factor 7.460]

Rivard, N.; L´Allemain, G.; Bártek, J.; Pouysségur, J.

Abrogation of p27(Kip1)by cDNA antisense suppresses quiescence (G(0)state) in fibroblasts

[year of publication 2006, impact factor 7.452]

Lukas, J.; Jadayel, D.; Bartkova, J.; Nacheva, E.; Dyer, M.J.S.; Strauss, M.; Bartek, J.

BCL-1/cyclin D1 oncoprotein oscillates and subverts the G1 phase control in B-cell neoplasms carrying the t(11;14) translocation

[year of publication 2006, impact factor 7.387]

Lukas, J.; Pagano, M.; Staskova, Z.; Draetta, G.; Bartek, J.

Cyclin D1 protein oscillates and is essential for cell cycle progression in human tumour cell lines

[year of publication 2006, impact factor 7.387]

Kim, J.S.; Souček, J.; Matoušek, J.; Raines, R.T.

Structural basis for the biological activities of bovine seminal ribo-nuclease

[year of publication 2006, impact factor 7.385]

Kim, J.S.; Souček, J.; Matoušek, J.; Raines, R.T.

Mechanism of ribonuclease cytotoxicity

[year of publication 2006, impact factor 7.385]

Fry, A.M.; Schultz, S.J.; Bartek, J.; Nigg, E.A.

Substrate specificity and cell cycle regulation of the Nek2 protein kinase, a potential human homolog of the mitotic regulator NIMA of Aspergillus nidulans

[year of publication 2006, impact factor 7.385]

Pytlík, R.; Stehlík, D.; Soukup, T.; Kalbáčová, M.; Rypáček, F.; Trč, T.; Mulínková, K.; Michnová, P.; Kideryová, L.; Živný, J.; Klener, P.jr.; Veselá, R.; Trněný, M.; Klener, P.

The cultivation of human multipotent mesenchymal stromal cells in clinical grade medium for bone tissue engineering

[year of publication 2009, impact factor 7.365]

Brissot, E.; Labopin, M.; Stelljes, M.; Ehninger, G.; Schwerdtfeger, R.; Finke, J.; Kolb, H.J.; Ganser, A.; Schäfer-Eckart, K.; Zander, A.R.; Bunjes, D.; Mielke, S.; Bethge, W.A.; Milpied, N.; Kalhs, P.; Blau, I.W.; Kröger, N.; Vitek, A.; et al.

Comparison of matched sibling donors versus unrelated donors in allogeneic stem cell transplantation for primary refractory acute myeloid leukemia: a study on behalf of the Acute Leukemia Working Party of the EBMT

[year of publication 2017, impact factor 7.333 ]

Jarolim, P.; Shayakul, C.; Prabakaran, D.; Jiang, L.; Stuart-Tilley, A.; Rubin, H.L.; Simova, S.; Zavadil, J.; Herrin, J.T.; Brouillette, J.; Somers, M.J.G.; Seemanova, E.; Brugnara, C.; Guay-Woodford, L.M.; Alper, S.L.

Autosomal dominant distal renal tubular acidosis is associated in three families with hererozygosity for the R589H mutation in the AE1 (band 3) Cl-/HCO3- exchanger

[year of publication 2006, impact factor 7.199]

Ianotto, J.-C.; Curto-Garcia, N.; Lauermannova, M.; et al.

Characteristics and outcomes of patients with essential thrombocythemia or polycythemia vera diagnosed before 20 years of age: a systematic review

[year of publication 2019, impact factor 7.116 ]

van Dorland, H.A.; Taleghani, M.M.; Sakai, K.; Friedman, K.D.; George, J.N.; Hrachovinova, I.; et al.

The International Hereditary Thrombotic Thrombocytopenic Purpura Registry: key findings at enrollment until 2017

[year of publication 2019, impact factor 7.116 ]

Robin, M.; De Wreede, L.C.; Wolschke, C.; Schetelig, J.; Eikema, D.-J.; Van Lint, M.T.; Knelange, N.S.; Beelen, D.; Brecht, A.; Niederwieser, D.; Vitek, A.; et al.

Long-term outcome after allogeneic hematopoietic cell transplantation for myelofibrosis

[year of publication 2019, impact factor 7.116 ]

Netuka, I.; Kvasnička, T.; Kvasnička, J.; Hrachovinová, I.; Ivák, P.; Mareček, F.; Bílková, J.; Malíková, I.; Jančová, M.; Malý, J.; Sood, P.; Sundareswaran, K.S.; Connors, J.M.; Mehra, M.R.

Evaluation of von Willebrand factor with a fully magnetically levitated centrifugal continuous-flow left ventricular assist device in advanced heart failure

[year of publication 2016, impact factor 7.114 ]

Scott, S.; Cartwright, A.; Francis, S.; Whitby, L.; Sanzone, A.P.; Mulder, A.; Galimberti, S.; Dulucq, S.; Mauté, C.; Lauricella, C.; Salmon, M.; Rose, S.; Willoughby, J.; Boeckx, N.; Palisgaard, N.; Maier, J.; Leibundgut, E.O.; Zizkova, H.; et al.

Assessment of droplet digital polymerase chain reaction for measuring BCR-ABL1 in chronic myeloid leukaemia in an international interlaboratory study

[year of publication 2021, impact factor 6.998 ]

Kayser, S.; Hills, R.K.; Langova, R.; Kramer, M.; Guijarro, F.; Sustkova, Z.; Estey, E.H.; Shaw, C.M.; Ráčil, Z.; Mayer, J.; Zak, P.; Baer, M.R.; Brunner, A.M.; Szotkowski, T.; Cetkovsky, P.; et al.

Characteristics and outcome of patients with acute myeloid leukaemia and t(8.16)(p11.p13): results from an International Collaborative Study*

[year of publication 2021, impact factor 6.998 ]

Romzova, M.; Smitalova, D.; Hynst, J.; Tom, N.; Loja, T.; Herudkova, Z.; Jurcek, T.; Stejskal, L.; Zackova, D.; Mayer, J.; Racil, Z.; Culen, M.

Hierarchical distribution of somatic variants in newly diagnosed chronic myeloid leukaemia at diagnosis and early follow-up

[year of publication 2021, impact factor 6.998 ]

Šálek, C.; Folber, F.; Froňková, E.; Pecherková, P.; Jelínková, H.; Hrabovský, Š.; Horáček, J.M.; Cetkovský, P.; Mayer, J.; Trka, J.; Doubek, M.

Low levels of minimal residual disease after induction chemotherapy for BCR-ABL1-negative acute lymphoblastic leukaemia in adults are clinically relevant

[year of publication 2021, impact factor 6.998 ]